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Abstract
It is currently admitted that Follicle-Stimulating Hormone (FSH) is physiologically involved in the development and function
of fetal/neonatal Sertoli cells in the rat but not the mouse. However, FSH is produced by both species from late fetal life
onwards. We thus reinvestigated the role of FSH in mouse testis development at day 0 (birth) 6, 8 and 10 post-partum (dpp)
by using mice that lack functional FSH receptors (FSH-R2/2). At birth, the number and proliferative index of Sertoli cells
were significantly lower in FSH-R2/2 mice than in wild type neonates. Claudin 11 mRNA expression also was significantly
reduced in FSH-R2/2 testes at 0 and 8 dpp, whereas the mRNA levels of other Sertoli cell markers (Transferrin and Desert
hedgehog) were comparable in FSH-R2/2 and wild type testes. Conversely, AMH mRNA and protein levels were higher at
birth, comparable at 6 dpp and then significantly lower in FSH-R2/2 testes at 8–10 dpp in FSH-R2/2 mice than in controls.
Although the plasma concentration of LH and the number of Leydig cells were similar in FSH-R2/2 and control (wild type),
testosterone concentration and P450c17 mRNA expression were significantly increased in FSH-R2/2 testes at birth.
Conversely, at 10 dpp when adult Leydig cells appear, expression of the steroidogenic genes P450scc, P450c17 and StAR
was lower in FSH-R2/2 testes than in controls. In conclusion, our results show that 1) like in the rat, signaling via FSH-R
controls Sertoli cell development and function during late fetal life in the mouse as well; 2) paracrine factors produced by
Sertoli cells are involved in the FSH-R-dependent regulation of the functions of fetal Leydig cells in late fetal life; and 3) the
role of FSH-R signaling changes during the prepubertal period.
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Introduction
During fetal life, Sertoli cells are the first to differentiate in the
gonad anlage. These large cells adhere one to the other and
surround the germ cells (or gonocytes) to form the seminiferous
cords [1]. This process occurs from 13.5 to 14.5 day post-
conception (dpc) in the rat and from 11.5 to 12.5 dpc in the
mouse. Then, Sertoli cells continue to proliferate until day 16 post-
partum (dpp) in the rat and 17 dpp in the mouse, when the Sertoli
cell population is definitively established. Finally, in adulthood,
spermatogenesis is quantitatively and qualitatively dependent on
the number and optimal function of Sertoli cells as they provide
the structural support necessary for germ cell maturation [2,3,4].
After the initial differentiation of Sertoli cells has occurred,
Leydig cells differentiate in the interstitial space [5,6,7,8]. In the
rat, fetal testis begins to produce testosterone at 15.5 dpc [9,10]
and expresses 3ß-hydroxysteroid dehydrogenase (3ß-HSD) from
14.5 dpc onwards [11]. In the mouse, testosterone production is
detected from 12.5 dpc onwards [12]. In the rat and mouse, the
functional activity of fetal Leydig cells decreases during late fetal
life and neonatal life, although this cell type may persist in adult
life, at least in the rat [13]. Another population of Leydig cells (i.e.
adult Leydig cells) starts to differentiate from 15 dpp in the rat [5],
whereas in the mouse they replace the fetal cells between 5 and
15 dpp [14,15,16]. The morphology and some physiological
features of adult Leydig cells differ from those of the fetal cells
[5,6,17].
In adult testes, Follicle Stimulating Hormone (FSH) is the major
endocrine regulator of Sertoli cell function. More than 300 genes
regulated by FSH have been identified by oligonucleotide
microarray analysis in cultured Sertoli cells from 20 dpp rat testes
[18]. Furthermore, in the adult, FSH also exerts a stimulatory
action on Leydig cell function [6,19,20,21,22]. As FSH receptors
(FSH-R) are expressed only by Sertoli cells and there is no
membrane contact between Sertoli and Leydig cells, this suggests
the existence of FSH-regulated paracrine factors that influence the
functions of Leydig cells. Indeed, many factors that are produced
by Sertoli cells and have a positive or negative effect on Leydig cell
function have been identified [5,23].
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The ontogeny of the control by FSH on the function and
development of Sertoli cells is well known in the rat. In the
pituitary, transcripts of FSHß gene are first detected by in situ
hybridization at 17.5 dpc. FSH-R mRNA is first detected at
14.5 dpc in Sertoli cells and these cells can respond to FSH from
15.5 dpc [24,25]. The pioneer work by Orth clearly showed that,
in rats, the proliferation of Sertoli cells is FSH-dependent during
late fetal life [26]. Specifically decapitation of rat fetuses at
18.5 dpc led to a decrease in Sertoli cell proliferation at 20.5 and
21.5 dpc that could be rescued by injections of FSH. Similarly,
using the fetal decapitation approach, we previously demonstrated
that the functions of Sertoli cells depend on the pituitary hormones
[27]. Lastly, FSH can influence the in vitro secretion of testosterone
by rat fetal testes as early as 15.5 dpc [25].
Conversely, the ontogeny of the control by FSH of fetal and
neonatal Sertoli cell development and function remains unclear in
the mouse. The common alpha-glycoprotein subunit is first
detected in the Rathke’s pouch in 11.5 dpc mice and the FSH
beta subunit in the anterior pituitary at 17.5 dpc [28]. In
hypogonadal (hpg) mice, which lack circulating gonadotropins,
the number of Sertoli cells is normal at 18.5 dpc but it is reduced
at the day of birth [29]. However, three studies from the same
laboratory using FSH and FSH-R deficient mice concluded that
the development and function of Sertoli and Leydig cells are
independent from FSH and FSH-R signaling during fetal and
early neonatal life [20,30,31].
It is thus necessary to reinvestigate the role of FSH in the
development and functions of fetal and neonatal testicular cells.
This is all the more important as fetal and neonatal testis is one of
the main targets of endocrine disruptors. To this aim, we analyzed
the development and functions of Sertoli, Leydig and germ cells at
the end of fetal life (birth) and at 6, 8 and 10 dpp in mice lacking
functional FSH-R [32].
Experimental Procedures
Animals
FSH-R deficient mice [32] were maintained under controlled
conditions of temperature (22uC), light (12L:12D) and humidity,
with food and water provided ad libitum. Colonies were maintained
by breeding heterozygous males with heterozygous females. Males
were genotyped by PCR analysis of genomic DNA using the
following oligonucleotides: 59-
ATGGCCTTGCTCCTGGTCTCCTTGCTGGCA-39 (reverse
primer), 59-AGAAAGCGAAGGAGCAAAGC-39 (forward prim-
er) and 59-TAGCCTTTGGTTAGGACAGCCCTATTTCA-39
(forward primer). The PCR conditions (40 cycles) were 96uC for
2 min, followed by 94uC for 1 min, 55uC for 2 min, 72uC for
2 min and a final extension at 72uC for 10 min. PCR products
were separated on 1% agarose gels to identify the 271 bp wild type
FSH-R and the 388 bp mutant FSH-R fragment. Both fragments
were present in heterozygous animals (data not shown).
Since the estimated time of ovulation was 02.00 a.m., the day
following the overnight mating was counted as 0.5 day post-
conception (dpc). Birth occurred spontaneously between 6 p.m. on
18.5 dpc and 10 a.m. on 19.5 dpc. Day 19.5 pc were counted as
0 dpp. The sex of the animals was determined by observation of
the ano-genital distance. Animals were sacrificed at 10 a.m. by
decapitation and their blood and testes were immediately
collected.
In some experiments, to limit individual variability and to
perform paired statistical tests, only one male from each genotype
was selected from the same litter for further analyses.
The animal facility is licensed by the French Ministry of
Agriculture (agreement NuB92-032-02). All animal experiments
were supervised by Pr. Rene´ Habert (agreement delivered by the
French Ministry of Agriculture for animal experiment Nu92–191)
in compliance with the NIH Guide for Care and Use of
Laboratory Animals [33]. All efforts were made to minimize
animal suffering.
Steroid extraction
Testosterone was extracted from testes as previously described
[34]. Briefly, testes were homogenized by sonication in 2 ml ethyl
acetate. After centrifugation, the ethyl acetate phase was removed
and kept. A second extraction was performed and the combined
ethyl acetate phases were vortexed for 1 min, dried under a heated
stream and re-dissolved at 50uC in 500 ml RIA buffer for
radioimmunoassay.
Testosterone RIA Assay
Testosterone concentration was measured by using a specific
RIA assay as described [34]. Briefly, 100 ml reconstituted testicular
extracts or testosterone standards were incubated at 4uC with
100 ml of anti-testosterone antibody (1:5,000; Covalab, France).
Then, the [3H]testosterone tracer (100 ml) was added and samples
were incubated at 4uC for another 2 h. Bound and free hormone
fractions were separated with dextran-charcoal and the amount of
bound testosterone was measured with a scintillation counter. The
minimum concentration of testosterone detectable in the medium
was 70 pg/ml. The intra- and inter-assay variations, determined
as the ratio between the SDs and the mean values of 15
determinations of the same solution containing 1 ng/ml testoster-
one, were 3% and 10%, respectively.
Gonadotrophin Immunofluorometric Assay
Plasma was separated and stored at 20uC. Plasma gonadotro-
phins concentrations were measured by using immunofluoro-
metric assays, as initially described for LH [35] and FSH [36]
using 25 ml (LH) and 30 ml (FSH) plasma in duplicate for each
sample. To further validate this method we made a dilution series
of rat and mouse pituitaries to cover the whole analysis range of
the assays. The results show that the samples can be analyzed in a
linear manner over the whole standard ranges; 0,04–16,0 ng/ml
in the LH assay (rat, R2 = 0,9924; mouse, R2= 0,9997) and 1,0–
12,5 ng/ml in the FSH assay (rat, R2 = 0,9912; mouse,
R2 = 0,9943). The limits of sensitivity of the assays are 0,03 and
0,1 ng/ml in the plasma for LH and FSH, respectively. The intra
assay coefficients of variation are around 10% and 5% respectively
for LH and FSH at the concentration levels measured in this
study.
Morphometric analysis of Sertoli, Leydig and germ cells
Sertoli cells and gonocytes. Sertoli cells and gonocytes in
testes from FSH-R2/2 and control littermates were identified and
counted based on previously described morphological criteria
(Fig. 1) [12,37]. The accuracy of the counting method was assessed
based on two criteria. First, the minimum number of sections to be
counted was identified such that the calculated number of total
cells was similar to the one obtained by counting a larger number
of sections. Second, we checked that similar numbers of cells were
obtained for both testes of the same animal. To this aim, we
mounted one out of 20 sections in order to count gonocytes and
Sertoli cells in at least nine sections that were equidistantly
distributed along the testis. The sum of the values for each testis
was multiplied by 20 to obtain the crude count (CC) per testis. The
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Abercrombie’s formula was used to correct for double counting,
which results from the presence of a cell in two successive sections:
TC=CC6S/(S+D), where TC is the true count, S is the section
thickness (5 mm), and D is the true mean diameter of the cell
nuclei. D corresponds to the mean of the nuclear diameters
measured (DM) on the section divided by p/4 to correct for the
over-expression of smaller profiles in sections through spherical
particles. DM was calculated in each testis based on at least 100
random determinations with a computerized video micrometer
(Microvision Instruments). This counting method has been
previously validated [37]. It provides values similar with those
obtained by disector methods [29].
Leydig cells. Leydig cells were identified by immunohisto-
chemical detection of 3ß-HSD, using an antibody provided by Dr.
G. Defaye (INSERM Unite´ 244, Grenoble, France) (Fig. 1).
Immunostaining was performed with the Vectastain Elite ABC kit
(Vector Laboratories), as described previously [12,38]. All 3ß-
HSD-positive cells in every 10 sections were counted and the
cumulative number per testis thus obtained was multiplied by 10
to obtain the crude count (CC). To correct for any double
counting resulting from the appearance of a cell in two successive
sections, the Abercrombie’s formula was used. This counting
method has been previously validated [12,38]. It provides values
similar with those obtained by disector methods [29].
All counts were done blind.
Measurement of bromodeoxyuridine incorporation
Newborn mice were intraperitoneally injected with 50 mg/kg
body weight of a 5-bromo-29-deoxyuridine (BrdU) and 5-fluoro-
29deoxyuridine solution, according to the manufacturer’s recom-
mendations (Cell Proliferation Kit; Amersham, Buckinghamshire,
UK) 3 h before sacrifice. BrdU incorporation in proliferating cells
was detected by immunohistochemistry, as described previously
[33]. The BrdU incorporation index (percentage of labeled Sertoli
cells) was obtained by counting at least 1000 Sertoli cells.
Immunohistochemical analysis of AMH expression
Immunostaining for Anti-Mullerian Hormone (AMH) was
performed as previously described using anti-AMH antibodies,
kindly provided by N. Di Clemente (INSERM 782, Clamart,
France) [37]. To compare the intensity of the staining in
FSH-R2/2 and controls, FSH-R2/2 and FSH-R+/+ testis sections
were mounted on the same slide and were immunostained in the
same drop. Negative controls, without the primary antisera, were
included in each experiment and no AMH expression could be
detected (not shown).
RNA extraction and analysis by real-time quantitative
PCR (Q-PCR)
Total RNA was extracted from 0, 8 and 10 dpp testes with the
RNeasy Micro Kit (Qiagen, Courtaboeuf, France) and reverse
transcribed using the QuantiTect Reverse Transcription Kit
(Qiagen, Courtaboeuf, France). Q-PCR was then performed on
an ABI PRISM 7000 Sequence Detector System using the
TaqMan PCR Master Mix (Applied Biosystems, France). AMH,
Transferrin, Desert hedgehog (Dhh), Claudin 11 (Osp), P450 Side-
Chain-Cleavage (P450scc), Steroidogenic acute regulatory protein
(StAR), P450 17a-hydroxylase/c17-20 lyase (P450c17), Gata-6
and ß-Actin transcripts were detected using the following TaqMan
gene expression assays (Applied Biosystems, Courtaboeuf, France):
Mm00431795-g1, Mm00446708-m1, Mm01310203-m1,
Mm00500915-m1, Mm00490735-m1, Mm00441558-m1,
Mm00484040-m1, Mm00802636-m1 and Mm00607939-S1. Q-
PCR was performed and data analyzed as previously described
[33].
As no endogenous control gene specifically expressed in Leydig
cells is known, and as the number of Sertoli cells was reduced in
FSH-R -/- testes whereas that of Leydig cells was unchanged
leading to an increase of the proportion of Leydig cells in the testis,
the mRNA expression of steroidogenic genes was normalized to an
exogenous internal reference mRNA [20,39]. Furthermore, this
procedure allows standardization for variations in the efficiency of
RNA extraction and reverse transcription and for RNA degrada-
tion. The reference was 5 ng of luciferase mRNA (Promega) that
were added to each testis at the start of the RNA extraction
procedure. Briefly, we extracted RNA from each testis into the
same volume of buffer (20 ml) and qPCR was performed with the
same volume of RNA extracts (0.4 ml). Thus, all RT-qPCR were
performed from 2% of the testis and thus from 2% of each cell
types contained in the testis. After sample processing, the
recovered quantities of luciferase and target mRNAs were
independently measured by multiplex real-time PCR and the
sample of luciferase mRNA was then used as a normalization
factor to control for the loss of mRNA during the cell lysis, RNA
isolation, DNA removal steps and reverse transcription. The
advantage of this approach is that measurements are expressed per
testis i.e. for the same number of Leydig cells.
Statistical analysis
All values are the mean 6 SEM. The significance of the
differences between the mean values of body weight was evaluated
with the Mann and Whitney U test. Data from FSH-R2/2, FSH-
R2/+ and FSH-R+/+ testes were compared using the Student’s
paired t-test or Student’s unpaired t-test for samples from the same
littermate, or different littermates respectively.
Figure 1. Identification of the testis cell types. Representative
microphotograph of a section from a wild type mouse testis at 0 dpp
after immunostaining for 3b-HSD and counterstaining with hematox-
ylin-eosin. The large arrow indicates 3b-HSD-positive Leydig cells.
Gonocytes (arrowheads) were identified by their large, spherical, lightly
stained nuclei that contain fine chromatin granules and two or more
globular nucleoli, and by the clearly visible cytoplasmic membrane.
Sertoli cells (smaller arrows) were identified based on their basal
position in the seminiferous cords and their cytological features
(irregular nucleus and no clear cytoplasmic membrane).
doi:10.1371/journal.pone.0053257.g001
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Results
Morphometric studies
Body weights of the mice were unchanged after FSH-R
deficiency at 0 dpp: 1.7360.08 g in FSH-R+/+ (n = 18),
1.8360.08 g in FSH-R+/2 (n = 25) and 1.6560.07 g in FSH-
R2/2 mice (n= 29).
Development and function of Sertoli cells
At birth (0 dpp), the histology of FSH-R2/2 and FSH-R+/+
testes was comparable with similar number of gonocytes. Indeed,
the total number of gonocytes is already determined by 15.5 dpc,
when they enter the quiescent period [3], and thus before the onset
of FSH secretion [28]. Conversely, the number of fetal Sertoli cells
was reduced by 22% in testes from FSH-R2/2 mice in
comparison to wild type animals (Fig. 2), whereas the mean
diameter of Sertoli cell nuclei was not significantly different.
Furthermore, BrdU incorporation in Sertoli cells was significantly
lower in FSH-R2/2 than in FSH-R+/+ testes (Fig. 2).
To determine the role(s) of FSH in the function of fetal Sertoli
cells, the expression of Sertoli cell-specific markers was assessed by
Q-PCR (Fig. 3). The relative expression (normalized to bactin) of
the transcription factor GATA-6, a member of the GATA-binding
protein family that is specifically expressed in Sertoli cells [40], was
decreased by 30% in FSH-R2/2 neonatal testes in comparison to
wild type testes, in line with the 22% reduction in the number of
Sertoli cells. This result is in agreement with the fact that GATA-6
mRNA expression is not FSH-dependent [41]. Therefore, we then
normalized the mRNA levels of Sertoli cell marker by using
GATA-6 as an endogenous reference. Both Transferrin [42,43] and
Dhh mRNA levels were comparable in FSH-R2/2 and FSH-R+/+
testes throughout post-natal development. Conversely, the expres-
sion of Claudin 11, which is involved in testis organogenesis and in
the development of tight junction intermembranous strands
between Sertoli cells [44], was significantly reduced in 0 and
8 dpp FSH-R2/2 testes. Finally, AMH was used to determine the
differentiation status of Sertoli cells because its expression sharply
drops during the perinatal and prepubertal periods [45]. AMH
mRNA level was 2.3-fold higher in 0 dpp FSH-R2/2 testes and
was significantly decreased in 8 dpp FSH-R2/2 testes in
comparison to FSH-R+/+ controls. This dynamic change in
AMH expression was confirmed by immunohistochemical anal-
ysis. In comparison to wild type FSH-R+/+ controls of the same
age, AMH staining in FSH-R2/2 testis sections was clearly
stronger at 0 dpp, comparable at 6 dpp (with heterogeneous
staining from one seminiferous cord to another) and strongly
reduced at 10 dpp in FSH-R2/2 testes (Fig. 4).
Development and function of Leydig cells
At birth, the morphological arrangement of Leydig cells in
clusters (Fig. 1) and the number of 3ß-HSD-positive cells was
comparable in FSH-R2/2 and FSH-R+/+ testes of littermates
(Fig. 2). Surprisingly, the mean testosterone concentration was
significantly higher in testes from FSH-R2/2 mice than from wild
type littermates, despite the high individual variability (Fig. 5A).
To determine the cause of this effect, the expression of genes
coding for various proteins involved in testicular steroidogenesis
(P450scc, P450c17 and StAR) was analyzed by Q-PCR and
normalized to an external standard (luciferase). The mean
expression level of P450scc, P450c17 and StAR at birth was higher
in testes from FSH-R2/2 animals than from control littermates,
and this difference was significant for P450c17 (Fig. 5B).
Conversely, at 10 dpp, when adult Leydig cells appear, their
expression was strongly reduced in FSH-R2/2 in comparison to
wild type testes (Fig. 5B), as previously described [20].
Determination of LH and FSH plasma levels
The activity of the hypothalamic-pituitary axis is regulated by a
feedback loop operating from the gonads. To determine whether
this control was altered in the absence of FSH signaling, we
measured the plasma concentration of FSH and LH (Fig. 6). At
birth, LH and FSH plasma levels were comparable in FSH-R2/2
and wild type animals. Conversely, at 8 dpp, FSH level was
increased by 2.3-fold in FSH-R2/2 animals, whereas no change in
LH levels was detected.
Figure 2. Effect of FSH-R deficiency on the number of testis
cells at birth. Upper panel. Number of gonocytes, Leydig cells and
Sertoli cells per testis in FSH-R2/2 and FSH-R+/+ mice at birthday (0 day
post partum (dpp)). Values are the mean 6 SEM from 5–6 animals for
each group. *, P,0.05 using the Student’s unpaired-t test. Lower panel
BrdU was injected in 0 dpp mouse neonates 3 h before sacrifice. Testes
were fixed and BrdU incorporation in the nuclei of Sertoli cells was
determined by immunohistochemistry (right panel). Labeled (arrow)
and unlabeled (arrowhead) cells were counted. The identification of
Sertoli cells was facilitated by staining with an anti-AMH antibody
(pink). The percentage of BrdU-positive Sertoli cells was determined by
counting at least 1000 Sertoli cells and presented as mean 6 SEM (left
panel) ). n = 6 ; **, P,0.01 using the Student’s unpaired-t test.
doi:10.1371/journal.pone.0053257.g002
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Discussion
This study shows for the first time that, in the absence of FSH
signaling the development and function of Sertoli and Leydig cells
are altered during late fetal life in the mouse. Furthermore, many
of the effects due to the absence of FSH signaling during fetal life
are different or opposite to those observed during prepubertal
period.
Sertoli cells divide during the fetal and neonatal periods and
cease to proliferate at 17–18 dpp [3,4]. We found that the number
of Sertoli cells and their proliferative index were significantly
reduced at birth in FSH-R2/2 mice, suggesting that FSH
produced during late fetal life promotes the proliferative activity
of Sertoli cells. This finding is consistent with the proliferative role
of FSH largely previously described during late fetal life in the rat
[26,27]. To evaluate fetal Sertoli cell function and differentiation,
we assessed the expression of selected Sertoli cell-specific markers.
Claudin 11 is expressed by Sertoli cells and is implied in testicular
organogenesis and development of tight junction intermembra-
nous strands between Sertoli cells [44]. The significant reduction
of Claudin 11 mRNA expression in 0 and 8 dpp FSH-R2/2 testes
is an evidence of the physiological effect of FSH on Sertoli cell
function in late fetal life. Conversely, Transferrin expression was not
affected in mice lacking FSH signaling, indicating that, differently
from adult life, FSH is not required for Transferrin expression
during fetal, neonatal and prepubertal life. Lastly, we tested AMH
expression that is a perfect marker for determining the state of
Sertoli cell differentiation because its expression sharply drops
during the perinatal and prepubertal period [45]. FSH-R
deficiency induced a rise in AMH mRNA and protein levels at
birth. This is in accordance with our previous work showing that
decapitation increases AMH expression during late fetal life in the
rat [27]. Furthermore, we show here a clear developmental switch
from a negative to a positive action of FSH signaling on AMH
expression around post-natal day 6. This finding might help
clarifying the contradictory results about the effects of FSH
administration on AMH expression described in two previous
works. As AMH expression was reported to be reduced at 4 dpp in
one study [46] and to be increased at 7 dpp in the other one [45]
our finding reconciles these data.
Early differentiation of fetal Leydig cells is independent from
pituitary hormones [15,34]. In the rat, the activity of fetal Leydig
cells, but not their differentiation, becomes dependent from LH
only during late fetal life [47]. The higher testosterone concen-
tration and P450c17 mRNA expression in FSH-R2/2 than in wild
type testes at birth suggest that FSH signaling controls the activity
of Leydig cells during late fetal life also in the mouse, although LH
plasma levels were comparable in the two groups of mice. The
number of Leydig cells was similar in FSH-R2/2 and wild type
testes at birth. This was expected because the number of Leydig
cells does not change significantly between 16 dpc and 5 dpp in
mice and FSH is produced only after 17 dpc [28,29]. Surprisingly,
our results show that FSH signaling physiologically inhibits the
steroidogenic activity of fetal Leydig cells at birth, whereas it is
known to positively regulate the activity of adult Leydig cells
[5,6,19,48]. Accordingly, we observed this positive effect of FSH in
10 dpp testes, when adult Leydig cells arise.
As it is generally acknowledged that fetal Leydig cells do not
express FSH-R, our results imply that Sertoli cells produce one or
more factors that act on Leydig cells during late fetal life. We thus
assessed the expression of two important Sertoli cell-derived
factors (AMH and Dhh) which may be involved in the regulation
of fetal Leydig cell development [49,50,51,52]. Dhh expression
was unaffected by FSH-R deficiency, whereas that of AMH was
increased. However, the effects of FSH on testosterone production
Figure 3. Effect of FSH-R deficiency on the expression of Sertoli
cell markers. RNA was extracted from whole testes of FSH-R2/2 and
wild type mice at 0 and 8 dpp and reverse transcribed. The expression
levels of specific Sertoli cell markers were then measured by real time
Q-PCR and normalized to GATA-6 mRNA expression. Results are
expressed as the percentage of expression relative to that of wild type
controls. Values are the mean 6 SEM of 8–9 animals for each group.
*, P,0.05; ***, P,0.001 using the Student’s unpaired-t test.
doi:10.1371/journal.pone.0053257.g003
Figure 4. Effect of FSH-R deficiency on AMH expression. Testes
were removed from FSH-R2/2 and control (FSH-R+/+) mice at 0, 6 and
10 dpp, fixed in Bouin’s fluid, immunostained for AMH and counter-
stained with hematoxylin. Scale bars = 50 mm. Insets, higher magnifica-
tions : scale bars = 10 mm.
doi:10.1371/journal.pone.0053257.g004
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are unlikely to result from an action of AMH because a previous
study in the rat demonstrated that AMH has an inhibitory effect
on the amount of testosterone produced by fetal Leydig cells [52].
We also investigated the effect of FSH-R deficiency on the
plasma gonadotropins levels. We previously observed an increase
in LH plasma levels after in utero castration of male rat fetuses
showing that the fetal testis exerts a negative feedback during late
fetal life in the rat [53]. In the present study, no changes could be
detected in LH level at both 0 and 8 dpp and in FSH at 0 dpp.
This may be due to the weakness of the changes in plasma
testosterone and inhibin levels induced by FSH-R deficiency and
to the high individual variability in LH plasma level. On the
contrary the expected increase in plasma FSH level was observed
at 8 dpp.
Our results are different from those described in previous works
by O’Shaughnessy’s laboratory [20,30] Specifically, they reported
that FSH-R deficiency did not affect Sertoli and Leydig cells
number at 1, 5 and 20 dpp and decreased these numbers only in
adults. The expression of Claudin 11 was unchanged at 5 and
20 dpp and was decreased only in adults. In the same way, a
reduction in AMH expression was observed only after 20 dpp.
Similarly, they reported that the testicular concentration of
testosterone level was normal in FSH-R2/2 animals during
neonatal and prepubertal life up to 20 dpp. They concluded that
FSH does not control the fetal and early neonatal development
and function of Leydig and Sertoli cells. In a very recent paper,
O’Shaughnessy and coll. confirmed their previous data [31]. At
birth, they observed no significant difference between control and
FSH-R KO mice for all the parameters that they measured
(testicular volume, tubule diameter, Sertoli, germ and Leydig cells
numbers). The number of Sertoli cells was not significantly
reduced at 5 dpp and even at 20 dpp. They also studied the effects
on testis development of ablating FSH-R in mice with ablation of
Androgen Receptors ubiquitously (ARKO) or specifically in the
Sertoli cells (SCARKO). Interestingly, they observed that a
deletion of FSH-R in SCARKO mice reduced the number of
Sertoli cells at birth. But this effect was no longer observed at
Figure 5. Effect of FSH-R deficiency on testis steroidogenic
activity. A: Testosterone concentration was measured in FSH-R+/+, FSH-
R+/2 and FSH-R2/2 testes. In 10 litters, one fetus of each genotype was
used. Values are the mean 6 SEM the 10 animals. *, P,0.05 using the
Student’s paired-t test. B: RNA was extracted from whole testes of mice
at 0 and 10 dpp and reverse transcribed. The expression levels of
specific steroidogenic genes were measured by real time Q-PCR and
normalized to an external standard (luciferase). Results are expressed as
the percentage of the expression in FSH-R2/2 testes relative to that of
controls, arbitrarily set at 100%. Values are the mean 6 SEM of 5–6
animals for each group. *, P,0.05 using the Student’s unpaired-t test.
doi:10.1371/journal.pone.0053257.g005
Figure 6. Effect of FSH-R deficiency on LH and FSH plasma
levels. LH and FSH concentrations were measured in plasma samples
from FSH-R2/2 and FSH-R+/+ mice at 0 dpp and 8 dpp. Values are the
mean 6 SEM of 5–6 plasma pools. *, P,0.05 using the Student’s
unpaired-t test.
doi:10.1371/journal.pone.0053257.g006
Testicular Development in FSH-R Deficient Mice
PLOS ONE | www.plosone.org 6 December 2012 | Volume 7 | Issue 12 | e53257
5 dpp. Furthermore, deletion of FSH-R in ARKO mice did not
significantly change the number of Sertoli cells at birth, at 5 dpp
and at 20 dpp. Taken together, this paper suggests that FSH
signaling is normally inefficient during fetal and neonatal life but it
can work in certain specific conditions.
These important discrepancies with our findings may be due to
several reasons. First, the portions of the R-FSH gene deleted are
slightly different. O’Shaughnessy et al. used FSH-R2/2 mice in
which exon 1, the 59 region including the transcriptional start site
and part of intron 1 were ablated [54] whereas in our FSH-R2/2
mouse model only exon 1 of FSH-R was missing [32]. It cannot be
excluded that the deletion of the transcriptional start site would
have creates a new transcriptional start site. Second, though both
studies used the same mouse strain, ES cells from 129SV mice
injected in C57BL/6 blastocysts, recombinations which occurred
during backcrosses are different giving rise to different genetic
backgrounds. Third, more importantly, O’Shaughnessy et al.
compared FSH-R2/2 animals with FSH-R+/2 animals used as
controls, whereas our controls were FSH-R+/+ mice. Indeed, in
accordance with O’Shaughnessy’s data, we observed that there is
no statistical difference in testicular testosterone content between
FSH-R2/2 and FSH-R+/2 pups, even when using animals issued
from the same littermates.
O’Shaughnessy’s et al. reported some differences in Leydig cell
function between FSH2/2 and FSH-R2/2, suggesting that FSH-
R is partly constitutively active [20]. This raises the question of
whether the effects we observed are solely the result of FSH-R
ablation or can be analyzed as the consequence of the suppression
of the action of circulating FSH. Many data argue for the second
hypothesis. First, FSH is expressed as soon as late fetal life in the
mouse [28]. Second, mouse fetal testes respond to FSH as early as
14.5 dpc in organotypic culture systems [12]. Third, in hypogo-
nadal (hpg) mice, which lack circulating gonadotropins, a
reduction in the number of Sertoli cells was observed at day of
birth [29]. Lastly, differences between FSH2/2 and FSH-R2/2
reported by O’Shaughnessy et al. never affected any Leydig or
Sertoli morphometrical, functional or molecular parameters
before 20 dpp suggesting that the constitutive activity of FSH-R
does not work during fetal and neonatal life [20,30].
In conclusion, by invalidating FSH-R in the mouse, we
demonstrated for the first time that, at the end of fetal life, FSH
signaling and probably FSH itself physiologically regulate the
proliferation and differentiation of Sertoli cells and the secretion
by Sertoli cells of paracrine factors which modulate Leydig cell
functions. Furthermore, most of the FSH signaling-dependent
effects observed during fetal/neonatal life differ from those
observed in prepubertal testis. This brings a new concept in the
endocrinology of the fetal and neonatal testis that is opposite to the
usually accepted belief that FSH is not involved in the control of
the development of fetal and neonatal testis in the mouse. This
reinforces the general concept that the fetal/neonatal testis has its
specific endocrine regulations and that it is not a ‘‘mini-adult’’
testis. A better understanding of the endocrinology of fetal testis is
now required, especially because it is a very sensitive target of
endocrine disruptors [55,56].
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